Corrigendum: Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders (Journal of Allergy and Clinical Immunology (2017) 139(1) (232–245)(S0091674916306248)(10.1016/j.jaci.2016.05.042));Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 1, 2017, Pages 232-245

  Stray Pedersen, Asbjørg ^a,b,c   Sorte, Hanne Sørmo ^c,d   Samarakoon, Pubudu ^c,d   Gambin, Tomasz ^a,e   Chinn, Ivan K ^a,b   Coban Akdemir, Zeynep H ^a   Erichsen, Hans Christian ^c   Forbes, Lisa R ^a,b   Gu, Shen ^a   Yuan, Bo ^a   Jhangiani, Shalini N ^a   Muzny, Donna M ^a   Rødningen, Olaug Kristin ^c   Sheng, Ying ^c   Nicholas, Sarah K ^a,b   Noroski, Lenora M ^b   Seeborg, Filiz O ^b   Davis, Carla M ^b   Canter, Debra L ^b   Mace, Emily M ^a,b   Vece, Timothy J ^b   Allen, Carl E ^a,b   Abhyankar, Harshal A ^a,b   Boone, Philip M ^a   Beck, Christine R ^a   Wiszniewski, Wojciech ^a   Fevang, Børre ^d,f   Aukrust, Pål ^d,f   Tjønnfjord, Geir E ^c,d   Gedde Dahl, Tobias ^c   Hjorth Hansen, Henrik ^g,h   Dybedal, Ingunn ^c   Nordøy, Ingvild ^d,f   Jørgensen, Silje F ^f   Abrahamsen, Tore G ^c,d   Øverland, Torstein ^c   Bechensteen, Anne Grete ^c   Skogen, Vegard ⁱ   Osnes, Liv T N ^c   Kulseth, Mari Ann ^c   Prescott, Trine E ^c   Rustad, Cecilie F ^c   Heimdal, Ketil R ^c   Belmont, John W ^a   Rider, Nicholas L ^a,b   Chinen, Javier ^b   Cao, Tram N ^a,b   Smith, Eric A ^a   Caldirola, Maria Soledad ^j   Bezrodnik, Liliana ^j   Lugo Reyes, Saul Oswaldo ^k   Espinosa Rosales, Francisco J ^k   Guerrero Cursaru, Nina Denisse ^l   Pedroza, Luis Alberto ^l   Poli, Cecilia M ^a,m   Franco, Jose L ⁿ   Trujillo Vargas, Claudia M ⁿ   Aldave Becerra, Juan Carlos ^o   Wright, Nicola ^p   Issekutz, Thomas B ^q   Issekutz, Andrew C ^q   Abbott, Jordan ^r   Caldwell, Jason W ^s   Bayer, Diana K ^t   Chan, Alice Y ^u   Aiuti, Alessandro ^v   Cancrini, Caterina ^w   Holmberg, Eva ^x   West, Christina ^y   Burstedt, Magnus ^x   Karaca, Ender ^a   Yesil, Gözde ^a,z   Artac, Hasibe ^aa   Bayram, Yavuz ^a   Atik, Mehmed Musa ^a   Eldomery, Mohammad K ^a   Ehlayel, Mohammad S ^ab   Jolles, Stephen ^ac   Flatø, Berit ^c   Bertuch, Alison A ^a,b   Hanson, I Celine ^a,b   Zhang, Victor W ^a   Wong, Lee Jun ^a   Hu, Jianhong ^a   Walkiewicz, Magdalena ^a   Yang, Yaping ^a   Eng, Christine M ^a   Boerwinkle, Eric ^a,ad   Gibbs, Richard A ^a   Shearer, William T ^b   Lyle, Robert ^c   Orange, Jordan S ^a,b   Lupski, James R ^a,b   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

ⁱ UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^j HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^k INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^l UNIVERSIDAD SAN FRANCISCO DE QUITO   (Ecuador)

^m UNIVERSITY OF CHILE   (Chile)

ⁿ UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^o HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^p ALBERTA CHILDREN'S HOSPITAL   (Canada)

^q DALHOUSIE UNIVERSITY   (Canada)

^r DEPARTMENT OF MEDICINE   (United States)

^s WAKE FOREST BAPTIST HEALTH   (United States)

^t UNIVERSITY OF IOWA   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^w UNIVERSITY OF ROME TOR VERGATA   (Italy)

^x UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^y UMEÅ UNIVERSITY   (Sweden)

^z BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^aa SELCUK UNIVERSITY   (Turkey)

^ab HAMAD MEDICAL CORPORATION   (Qatar)

^ac UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^ad UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

copy number variants; Primary immunodeficiency disease; whole exome sequencing

Indexed keywords

DYSKERIN; FANCONI ANEMIA GROUP A PROTEIN; PROTEIN; PROTEIN DOCK8; PROTEIN IKZF1; PROTEIN MAGT1; PROTEIN MYB; PROTEIN PGM3; PROTEIN SMARCAL1; PROTEIN TERC; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW DEPRESSION; CHILD; CLINICAL STUDY; COPY NUMBER VARIATION; DIAGNOSTIC VALUE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENETIC VARIABILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MOSAICISM; NEWBORN; PHENOTYPE; PRIMARY IMMUNODEFICIENCY DISEASE; PRIORITY JOURNAL; WHOLE EXOME SEQUENCING; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA COPY NUMBER VARIATIONS; FEMALE; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84994399234     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.12.975     Document Type: Erratum

References (88)

1. 1 Picard, C., Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 35 (2015), 696–726.
2. 2 Stray-Pedersen, A., Abrahamsen, T.G., Froland, S.S., Primary immunodeficiency diseases in Norway. J Clin Immunol 20 (2000), 477–485.
3. 3 Al-Herz, W., Zainal, M.E., Alenezi, H.M., Husain, K., Alshemmari, S.H., Performance status and deaths among children registered in Kuwait National Primary Immunodeficiency Disorders Registry. Asian Pac J Allergy 28 (2010), 141–146.
4. 4 CEREDIH, Gathmann, B., Mahlaoui, N., Gerard, L., Oksenhendler, E., Warnatz, K., Schulze, I., et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134 (2014), 116–126.
5. 5 de Pagter, A.P., Bredius, R.G., Kuijpers, T.W., Tramper, J., van der Burg, M., van Montfrans, J., et al. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening. Eur J Pediatr 174 (2015), 1183–1188.
6. 6 Di Matteo, G., Giordani, L., Finocchi, A., Ventura, A., Chiriaco, M., Blancato, J., et al. Molecular characterization of a large cohort of patients with chronic granulomatous disease and identification of novel CYBB mutations: an Italian multicenter study. Mol Immunol 46 (2009), 1935–1941.
7. 7 Koker, M.Y., Camcioglu, Y., van Leeuwen, K., Kilic, S.S., Barlan, I., Yilmaz, M., et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol 132 (2013), 1156–1163.e5.
8. 8 Fattahi, F., Badalzadeh, M., Sedighipour, L., Movahedi, M., Fazlollahi, M.R., Mansouri, S.D., et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 31 (2011), 792–801.
9. 9 Chan, A., Scalchunes, C., Boyle, M., Puck, J.M., Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey. Clin Immunol 138 (2011), 3–8.
10. 10 Ghosh, S., Thrasher, A.J., Gaspar, H.B., Gene therapy for monogenic disorders of the bone marrow. Br J Haematol, 2015 [Epub ahead of print].
11. 11 Genovese, P., Schiroli, G., Escobar, G., Di Tomaso, T., Firrito, C., Calabria, A., et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature 510 (2014), 235–240.
12. 12 Hacein-Bey Abina, S., Gaspar, H.B., Blondeau, J., Caccavelli, L., Charrier, S., Buckland, K., et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA 313 (2015), 1550–1563.
13. 13 Pai, S.Y., Logan, B.R., Griffith, L.M., Buckley, R.H., Parrott, R.E., Dvorak, C.C., et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med 371 (2014), 434–446.
14. 14 Montiel-Equihua, C.A., Thrasher, A.J., Gaspar, H.B., Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency. Curr Gene Ther 12 (2012), 57–65.
15. 15 Henderson, C., Goldbach-Mansky, R., Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 22 (2010), 567–578.
16. 16 Milman, N., Andersen, C.B., Hansen, A., van Overeem Hansen, T., Nielsen, F.C., Fledelius, H., et al. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 114 (2006), 912–919.
17. 17 Aksentijevich, I., Masters, S.L., Ferguson, P.J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360 (2009), 2426–2437.
18. 18 Nijman, I.J., van Montfrans, J.M., Hoogstraat, M., Boes, M.L., van de Corput, L., Renner, E.D., et al. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies. J Allergy Clin Immunol 133 (2014), 529–534.
19. 19 Moens, L.N., Falk-Sorqvist, E., Asplund, A.C., Bernatowska, E., Smith, C.I., Nilsson, M., Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS One, 9, 2014, e114901.
20. 20 Al-Mousa, H., Abouelhoda, M., Monies, D.M., Al-Tassan, N., Al-Ghonaium, A., Al-Saud, B., et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol 137 (2016), 1780–1787.
21. 21 Yang, Y., Muzny, D.M., Reid, J.G., Bainbridge, M.N., Willis, A., Ward, P.A., et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 369 (2013), 1502–1511.
22. 22 Yang, Y., Muzny, D.M., Xia, F., Niu, Z., Person, R., Ding, Y., et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 312 (2014), 1870–1879.
23. 23 Schouten, J.P., McElgunn, C.J., Waaijer, R., Zwijnenburg, D., Diepvens, F., Pals, G., Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res, 30, 2002, e57.
24. 24 Conley, M.E., Notarangelo, L.D., Etzioni, A., Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93 (1999), 190–197.
25. 25 Bonilla, F.A., Khan, D.A., Ballas, Z.K., Chinen, J., Frank, M.M., Hsu, J.T., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol 136 (2015), 1186–1205 e1-78.
26. 26 Bonilla, F.A., Bernstein, I.L., Khan, D.A., Ballas, Z.K., Chinen, J., Frank, M.M., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94:suppl 1 (2005), S1–S63.
27. 27 Bousfiha, A., Jeddane, L., Al-Herz, W., Ailal, F., Casanova, J.L., Chatila, T., et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 35 (2015), 727–738.
28. 28 Bamshad, M.J., Ng, S.B., Bigham, A.W., Tabor, H.K., Emond, M.J., Nickerson, D.A., et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 12 (2011), 745–755.
29. 29 Lupski, J.R., Gonzaga-Jauregui, C., Yang, Y., Bainbridge, M.N., Jhangiani, S., Buhay, C.J., et al. Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy. Genome Med, 5, 2013, 57.
30. 30 Stray-Pedersen, A., Jouanguy, E., Crequer, A., Bertuch, A.A., Brown, B.S., Jhangiani, S.N., et al. Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy. J Clin Immunol 34 (2014), 871–890.
31. 31 Sulonen, A.M., Ellonen, P., Almusa, H., Lepisto, M., Eldfors, S., Hannula, S., et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol, 12, 2011, R94.
32. 32 Shigemizu, D., Momozawa, Y., Abe, T., Morizono, T., Boroevich, K.A., Takata, S., et al. Performance comparison of four commercial human whole-exome capture platforms. Sci Rep, 5, 2015, 12742.
33. 33 Reid, J.G., Carroll, A., Veeraraghavan, N., Dahdouli, M., Sundquist, A., English, A., et al. Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline. BMC Bioinformatics, 15, 2014, 30.
34. 34 Pollard, K.S., Hubisz, M.J., Rosenbloom, K.R., Siepel, A., Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 20 (2010), 110–121.
35. 35 Cooper, G.M., Stone, E.A., Asimenos, G., Green, E.D., Batzoglou, S., Sidow, A., et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 15 (2005), 901–913.
36. 36 Ng, P.C., Henikoff, S., SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31 (2003), 3812–3814.
37. 37 Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., et al. A method and server for predicting damaging missense mutations. Nat Methods 7 (2010), 248–249.
38. 38 Chun, S., Fay, J.C., Identification of deleterious mutations within three human genomes. Genome Res 19 (2009), 1553–1561.
39. 39 Schwarz, J.M., Cooper, D.N., Schuelke, M., Seelow, D., MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11 (2014), 361–362.
40. 40 Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17 (2015), 405–424.
41. 41 Itan, Y., Casanova, J.L., Novel primary immunodeficiency candidate genes predicted by the human gene connectome. Front Immunol, 6, 2015, 142.
42. 42 Casanova, J.L., Conley, M.E., Seligman, S.J., Abel, L., Notarangelo, L.D., Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med 211 (2014), 2137–2149.
43. 43 Samarakoon, P.S., Sorte, H.S., Kristiansen, B.E., Skodje, T., Sheng, Y., Tjonnfjord, G.E., et al. Identification of copy number variants from exome sequence data. BMC Genomics, 15, 2014, 661.
44. 44 Bayer, D.K., Martinez, C.A., Sorte, H.S., Forbes, L.R., Demmler-Harrison, G.J., Hanson, I.C., et al. Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol 178 (2014), 459–469.
45. 45 Stray-Pedersen, A., Backe, P.H., Sorte, H.S., Morkrid, L., Chokshi, N.Y., Erichsen, H.C., et al. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet 95 (2014), 96–107.
46. 46 Kuehn, H.S., Boisson, B., Cunningham-Rundles, C., Reichenbach, J., Stray-Pedersen, A., Gelfand, E.W., et al. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS. N Engl J Med 374 (2016), 1032–1043.
47. 47 Hayrapetyan, A., Dencher, P.C., van Leeuwen, K., de Boer, M., Roos, D., Different unequal cross-over events between NCF1 and its pseudogenes in autosomal p47(phox)-deficient chronic granulomatous disease. Biochim Biophys Acta 1832 (2013), 1662–1672.
48. 48 Hoyeraal, H.M., Lamvik, J., Moe, P.J., Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers. Acta Paediatr Scand 59 (1970), 185–191.
49. 49 Picard, C., Dogniaux, S., Chemin, K., Maciorowski, Z., Lim, A., Mazerolles, F., et al. Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. Eur J Immunol 39 (2009), 1966–1976.
50. 50 Huo, Y.K., Wang, Z., Hong, J.H., Chessa, L., McBride, W.H., Perlman, S.L., et al. Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res 54 (1994), 2544–2547.
51. 51 Lupski, J.R., Belmont, J.W., Boerwinkle, E., Gibbs, R.A., Clan genomics and the complex architecture of human disease. Cell 147 (2011), 32–43.
52. 52 Watkin, L.B., Jessen, B., Wiszniewski, W., Vece, T.J., Jan, M., Sha, Y., et al. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet 47 (2015), 654–660.
53. 53 Niemela, J.E., Lu, L., Fleisher, T.A., Davis, J., Caminha, I., Natter, M., et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood 117 (2011), 2883–2886.
54. 54 Milner, J.D., Vogel, T.P., Forbes, L., Ma, C.A., Stray-Pedersen, A., Niemela, J.E., et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125 (2015), 591–599.
55. 55 Siegel, A.M., Stone, K.D., Cruse, G., Lawrence, M.G., Olivera, A., Jung, M.Y., et al. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol 132 (2013), 1388–1396.
56. 56 Bornholdt, D., Atkinson, T.P., Bouadjar, B., Catteau, B., Cox, H., De Silva, D., et al. Genotype-phenotype correlations emerging from the identification of missense mutations in MBTPS2. Hum Mutat 34 (2013), 587–594.
57. 57 Corujeira, S., Agueda, S., Monteiro, G., Canelhas, A., Sampaio, M., Rocha, R., et al. Expanding the phenotype of IFAP/BRESECK syndrome: a new case with severe hypogammaglobulinemia. Eur J Med Gene 56 (2013), 603–605.
58. 58 Becker-Heck, A., Zohn, I.E., Okabe, N., Pollock, A., Lenhart, K.B., Sullivan-Brown, J., et al. The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation. Nat Genet 43 (2011), 79–84.
59. 59 Saunders, C., Smith, L., Wibrand, F., Ravn, K., Bross, P., Thiffault, I., et al. CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria. Am J Hum Genet 96 (2015), 258–265.
60. 60 Wortmann, S.B., Zietkiewicz, S., Kousi, M., Szklarczyk, R., Haack, T.B., Gersting, S.W., et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet 96 (2015), 245–257.
61. 61 Schubert, D., Bode, C., Kenefeck, R., Hou, T.Z., Wing, J.B., Kennedy, A., et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 20 (2014), 1410–1416.
62. 62 Kuehn, H.S., Ouyang, W., Lo, B., Deenick, E.K., Niemela, J.E., Avery, D.T., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345 (2014), 1623–1627.
63. 63 Gibbs, D.C., Orlow, I., Kanetsky, P.A., Luo, L., Kricker, A., Armstrong, B.K., et al. Inherited genetic variants associated with occurrence of multiple primary melanoma. Cancer Epidemiol Biomarkers Prev 24 (2015), 992–997.
64. 64 Barrett, J.H., Iles, M.M., Harland, M., Taylor, J.C., Aitken, J.F., Andresen, P.A., et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43 (2011), 1108–1113.
65. 65 Chen, K., Coonrod, E.M., Kumanovics, A., Franks, Z.F., Durtschi, J.D., Margraf, R.L., et al. Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet 93 (2013), 812–824.
66. 66 Liu, Y., Hanson, S., Gurugama, P., Jones, A., Clark, B., Ibrahim, M.A., Novel NFKB2 mutation in early-onset CVID. J Clin Immunol 34 (2014), 686–690.
67. 67 Lougaris, V., Tabellini, G., Vitali, M., Baronio, M., Patrizi, O., Tampella, G., et al. Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease. J Allergy Clin Immunol 135 (2015), 1641–1643.
68. 68 Sassi, A., Lazaroski, S., Wu, G., Haslam, S.M., Fliegauf, M., Mellouli, F., et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol 133 (2014), 1410–1419 e1-13.
69. 69 Zhang, Y., Yu, X., Ichikawa, M., Lyons, J.J., Datta, S., Lamborn, I.T., et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 133 (2014), 1400–1409 e1-5.
70. 70 Bernth-Jensen, J.M., Holm, M., Christiansen, M., Neonatal-onset T(−)B(−)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3. J Allergy Clin Immunol 137 (2016), 321–324.
71. 71 Gonzaga-Jauregui, C., Harel, T., Gambin, T., Kousi, M., Griffin, L.B., Francescatto, L., et al. Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep 12 (2015), 1169–1183.
72. 72 Vissers, L.E., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., et al. A de novo paradigm for mental retardation. Nat Genet 42 (2010), 1109–1112.
73. 73 Gilissen, C., Hehir-Kwa, J.Y., Thung, D.T., van de Vorst, M., van Bon, B.W., Willemsen, M.H., et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511 (2014), 344–347.
74. 74 Lupski, J.R., Reid, J.G., Gonzaga-Jauregui, C., Rio Deiros, D., Chen, D.C., Nazareth, L., et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 362 (2010), 1181–1191.
75. 75 Duzkale, H., Shen, J., McLaughlin, H., Alfares, A., Kelly, M.A., Pugh, T.J., et al. A systematic approach to assessing the clinical significance of genetic variants. Clin Genet 84 (2013), 453–463.
76. 76 de Ligt, J., Willemsen, M.H., van Bon, B.W., Kleefstra, T., Yntema, H.G., Kroes, T., et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367 (2012), 1921–1929.
77. 77 Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380 (2012), 1674–1682.
78. 78 Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 519 (2015), 223–228.
79. 79 Orange, J.S., Glessner, J.T., Resnick, E., Sullivan, K.E., Lucas, M., Ferry, B., et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 127 (2011), 1360–1367.e6.
80. 80 van Schouwenburg, P.A., Davenport, E.E., Kienzler, A.K., Marwah, I., Wright, B., Lucas, M., et al. Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol 160 (2015), 301–314.
81. 81 Karaca, E., Harel, T., Pehlivan, D., Jhangiani, S.N., Gambin, T., Akdemir, Z.C., et al. Genes that affect brain structure and function identified by rare variant analyses of Mendelian neurologic disease. Neuron 88 (2015), 499–513.
82. 82 Stoddard, J.L., Niemela, J.E., Fleisher, T.A., Rosenzweig, S.D., Targeted NGS: a cost-effective approach to molecular diagnosis of PIDs. Front Immunol, 5, 2014, 531.
83. 83 Raje, N., Soden, S., Swanson, D., Ciaccio, C.E., Kingsmore, S.F., Dinwiddie, D.L., Utility of next generation sequencing in clinical primary immunodeficiencies. Curr Allergy Asthma Rep, 14, 2014, 468.
84. 84 Picard, C., Fischer, A., Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur J Immunol 44 (2014), 2854–2861.
85. 85 Platt, C., Geha, R.S., Chou, J., Gene hunting in the genomic era: Approaches to diagnostic dilemmas in patients with primary immunodeficiencies. J Allergy Clin Immunol 134 (2014), 262–268.
86. 86 Meynert, A.M., Ansari, M., FitzPatrick, D.R., Taylor, M.S., Variant detection sensitivity and biases in whole genome and exome sequencing. BMC Bioinformatics, 15, 2014, 247.
87. 87 Kwan, A., Abraham, R.S., Currier, R., Brower, A., Andruszewski, K., Abbott, J.K., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 (2014), 729–738.
88. 88 Yu, H., Zhang, V.W., Stray-Pedersen, A., Hanson, I.C., Forbes, L.R., de la Morena, M.T., et al. Rapid molecular diagnostics of severe primary immunodeficiency by targeted next generation sequencing. J Allergy Clin Immunol 138 (2016), 1142–1151.e2.